Abstract
This paper reviews the current status of glutathione metabolism, methods that have been developed for the depletion of cellular glutathione and for increasing glutathione levels, and studies on the effects of modulation of cellular glutathione levels. Readers interested in earlier work on the enzymology, metabolism, transport, and functions of glutathione should consult several recent reviews (1–5).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Larsson A, Orrenius S, Holmgren A, Mannervik B (eds): Functions of Glutathione: Biochemical, Physiological, Toxicological, and Clinical Aspects, Raven Press, New York, 1983.
Meister A, Anderson ME: Glutathione. Ann. Rev. Biochem. 52: 711–760, 1983.
Arias IM, Jakoby WB (eds): Glutathione, Metabolism and Function. Kroc Foundation Series, Vol. 6, Raven Press, New York, 1976.
Meister A: New aspects of glutathione biochemistry and transport: Selective alteration of glutathione metabolism. Fed. Proc. 43: 3031–3042, 1984.
Sies H, Wendel A (eds): Function of Glutathione in Liver and Kidney, Springer-Verlag, New York, 1977.
Griffith OW, Meister A: Differential inhibition of glut-amine and γ-glutamylcysteine synthetases by a α-alkyl analogs of methionine sulfoximine that induce convulsions. J. Biol. Chem. 253: 2333–2338, 1978.
Griffith OW, Anderson ME, Meister A: Inhibition of glutathione biosynthesis by prothionine sulfoximine (S-n-propyl-homocysteine sulfoximine): A selective inhibitor of γ-glutamylcysteine synthetase. J. Biol. Chem. 254: 1205–1210, 1979.
Griffith OW, Meister A: Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J. Biol. Chem. 254: 7558–7560, 1969.
Griffith OW: Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J. Biol. Chem. 257: 13, 704–13, 712, 1982.
Williamson JM, Meister A: Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine4-carboxylate, a 5-oxo-L-prolinase substrate. Proc. Natl. Acad. Sci. U.S. 78: 936–939, 1981.
Williamson JM, Meister A: New substrates of 5-oxo-L-prolinase. J. Biol. Chem. 257: 12, 039–12, 042, 1982.
Williamson JM, Boettcher B, Meister A: An intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis. Proc. Natl. Acad. Sci. U.S. 79: 6246–6249, 1982.
Anderson ME, Meister A: Transport and direct utilization of γ-glutamylcyst(e) ine for glutathione synthesis. Proc. Natl. Acad. Sci. U.S. 80: 707–711, 1983.
Puri RN, Meister A: Transport of glutathione as γ-glutamylcysteinylglycyl ester into liver and kidney. Proc. Natl. Acad. Sci. U.S. 80: 5258–5260, 1983.
Wellner VP, Anderson ME, Puri RN et al: Radioprotection by glutathione ester: Transport of glutathione ester into human lymphoid cells and fibroblasts. Proc. Natl. Acad. Sci. U.S. 81: 4732–4735, 1984.
Anderson ME, Powrie F, Puri RN, Meister A: Glutathione monoethyl ester; preparation, uptake by tissues, and conversion to glutathione. Arch. Biochem. Biophys. 239: 538–548, 1985.
Meister A, Anderson ME, Hwang O: Intracellular cysteine and glutathione delivery systems. J. Am. Coll. Nut., in press, 1985.
Meister A, Griffith OW: Effects of methionine sulfoximine analogs on the synthesis of glutamine and glutathione: Possible chemotherapeutic implications. Cancer Treat. Rep. 63: 1115–1121, 1979.
Meister A: Selective modification of glutathione metabolism. Science 220: 471–477, 1983.
Richman P, Meister A: Regulation of γ-glutamyl-cysteine synthetase by nonallosteric feedback inhibition of glutathione. J. Biol. Chem. 250: 1422–1426, 1975.
Griffith OW, Meister A: Translocation of intracellular glutathione to membrane-bound γ-glutamyl transpeptidase as a discrete step in the γ-glutamyl cycle: Glutathionuria after inhibition of transpeptidase. Proc. Natl. Acad. Sci. U.S. 76: 268–272, 1979.
Griffith OW, Meister A: Glutathione: Interorgan translocation, turnover and metabolism. Proc. Natl. Acad. Sci. U.S. 76: 4932–4935, 1979.
Abbott WA, Bridges RJ, Meister A: Extracellular metabolism of glutathione accounts for its disappearance from the basolateral circulation of the kidney. J. Biol. Chem. 259: 15, 393–15, 400, 1984.
Meister A: 5-Oxoprolinuria (pyroglutamic aciduria) and other disorders of the γ-glutamyl cycle. In: Metabolic Basis of Inherited Disease, Stanbury JB, Wyngaarden J, Frederickson DS, Goldstein JL, Brown MS (eds), New York, McGraw-Hill, 1982, Vol. 10, pp. 348–359.
Meister A: Glutathione synthesis. In: The Enzymes, Boyer P (ed), New York, Academic Press, 1974, pp. 671–697.
Meister A: Glutamine synthetase of mammals. In: The Enzymes, Boyer P (ed), New York, Academic Press, 1974, Vol. 10, pp. 699–754.
Ronzio R, Meister A: Phosphorylation of methionine sulfoximine by glutamine synthetase. Proc. Natl. Acad. Sci. U.S. 59: 164–170, 1968.
Richman PG, Orlowski M, Meister A: Inhibition of γ-glutamyl-cysteine synthetase by L-methionine-S-sulfoximine. J. Biol. Chem. 248: 6684–6690, 1973.
Rowe WB, Meister A: Identification of L-methionine-S-sulfoximine as the convulsant isomer of methionine sulfoximine. Proc. Natl. Acad. Sci. U.S. 66: 500–506, 1970.
Ronzio RA, Rowe WB, Meister A: Studies on the mechanism of inhibition of glutamine synthetase by methionine sulfoximine. Biochemistry 8: 1066–1075, 1969.
Rowe WB, Ronzio RA, Meister A: Inhibition of glutamine synthetase by methionine sulfoximine, studies on methionine sulfoximine phosphate. Biochemistry 8: 2674–2680, 1969.
Manning JM, Moore S, Rowe WB, Meister A: Identification of L-methionine-S-sulfoximine as the diastereoisomer of L-methionine-SR-sulfoximine that inhibits glutamine synthetase. Biochemistry 8: 2681–2685, 1969.
Palekar AG, Tate SS, Meister A: Decrease in glutathione levels of kidney and liver after injection of methionine sulfoximine into rats. Biochem. Biophys. Res. Commun. 62: 651–657, 1975.
Meister A: Inhibition of glutamine synthetase and γ-glutamylcysteine synthetase by methionine sulfoximine and related compounds. In: Enzyme-Activated Irreversible Inhibitors, Seiler N, Jung MJ, Koch-Weser J (eds), Amsterdam, Elsevier-North Holland Biomedical Press, 1978, pp. 187–211.
Meister A: The specificity of glutamine synthetase and its relationship to substrate conformation at the active site. Adv. Enzymol. 31: 183–218, 1968.
Meister A: On the synthesis and utilization of glutamine. Harvey Lectures Series 63: 139–178, 1969.
Gass JD, Meister A: Computer analysis of the active site of glutamine synthetase. Biochemistry 9: 842–846, 1970.
Seddon AP, Meister A: Unpublished data.
Dethmers JK, Meister A: Glutathione export by human lymphoid cells: Depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation. Proc. Natl. Acad. Sci. U.S. 78: 7492–7496.
Clement J, Griffith OW, Meister A: Unpublished studies.
Mitchell JB, Rosso A, Biaglow JE, McPherson S: Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: No effect of glutathione depletion on the oxygen enhancement ratio. Rad. Res. 96: 422–428, 1983.
Guichard M, Jensen G, Meister A, Malaise EP: Depletion of glutathione synthesis by buthionine sulfoximine decreases the oxygen enhancement ratio of V79 cells. Proc. Radiat. Res. Soc, Abstract D-10, 1983.
Biaglow JE, Varnes ME, Clark EP, Epp ER: The role of thiols in cellular response to radiation and drugs. Radiat. Res. 95: 437–455, 1983.
Arrick BA, Nathan CF, Griffith OW, Cohn ZA: Glutathione depletion sensitizes tumor cells to oxidative cytolysis. J. Biol. Chem. 257: 1231–1237, 1982.
Arrick BA, Griffith OW, Cerami A: Inhibition of glutathione synthesis as a chemotherapeutic strategy for trypanosomiasis. J. Exp. Med. 153: 720–725, 1981.
Suzakake K, Petro BJ, Vistica DT: Reduction in glutathione content of L-PAM resistant L1210 cells confers drug sensitivity. Biochem. Pharmacol. 31: 121–124, 1982.
Suzukake K, Vistica BP, Vistica DT: Dechlorination of L-phenylalanine mustard by sensitive and resistant tumor cells and its relationship to intracellular glutathione content. Biochem. Pharmacol. 32: 165–167, 1983.
Vistica DT, Somfai-Relle S, Suzukake K, Petro B: Inhibition of glutathione biosynthesis by S-n-butyl homocysteine sulfoximine and sensitization of murine tumor cells resistant to L-phenylanine mustard. J. Cell. Biochem. Suppl. 6: 375, 1982.
Louie KG, Behrens BC, Kihsella TJ et al: Radiation survival parameters of antineoplastic drug-sensitive and resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. Cancer Res. 45: 2110–2115, 1965.
Green JA, Vistica DT, Young RC et al: Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion. Cancer Res. 44: 5427–5431, 1984.
Ozols R: This symposium.
Mitchell JB, Russo A, Kinsella TJ, Glatstein E: Glutathione elevation during thermotolerance induction and thermosensitization by glutathione depletion. Cancer Res. 43: 987–991, 1983.
Jensen GL, Meister A: Radioprotection of human lymphoid cells by exogenously-supplied glutathione is mediated by γ-glutamyl transpeptidase. Proc. Natl. Acad. Sci. U.S. 80: 4714–4717, 1983.
Meister A, Griffith OW: Effect of buthionine sulfoximine and related compounds on mitochondrial glutathione levels. Fed. Proc. 42: 2210, 1983.
Griffith OW, Meister A: Origin and turnover of mitochondrial glutathione. Proc. Natl. Acad. Sci. U.S. 82: 4668–4672, 1985.
Biaglow JE: This symposium.
Berggren M, Dawson J, Moldeus P: Glutathione biosynthesis in the isolated perfused rat lung: Utilization of extracellular glutatione. FEBS Letters 176: 189–192, 1984.
Tsan MF, Danis EH, Del Vecchio PJ, Rosano CL: Enhancement of intracellular glutathione protects endothelial cells against oxidant damage. Biochem. Biophys. Res. Commun. 127: 270–276, 1985.
Deneke SM, Lynch BA, Fanburg BL: Transient depletion of lung glutathione by diethylmaleate enhances oxygen toxicity. J. Appl. Physiol. 58: 571–574, 1985.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Meister, A. (1986). Modulation of Intracellular Levels of Glutathione. In: Valeriote, F.A., Baker, L.H. (eds) Biochemical Modulation of Anticancer Agents: Experimental and Clinical Approaches. Developments in Oncology, vol 47. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2331-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2331-0_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9432-0
Online ISBN: 978-1-4613-2331-0
eBook Packages: Springer Book Archive